EUVIMEDObjevte EUVIMED
EUVIMED · CrossrefJournal

Liver Cancer

ISSN 1664-5553 · S. Karger AG

Latest articles

  1. Survival Benefit of Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

    Hidekatsu Kuroda, Takuya Sho, Goki Suda, Masashi Ninomiya, Tamami Abe, Kei Endo, Takuya Watanabe, Yudai Fujiwara, Tokio Sasaki, Yuichi Yoshida, Keisuke Kakisaka, Takayoshi Oikawa, Kei Sawara, Mio Tsuruoka, Hiroshi Numao, Go Igarashi, Chikara Iino, Kenta Yoshida, Satoshi Sato, Tomohiro Katsumi, Keita Maki, Wataru Sato, Shinichiro Minami, Kazumichi Abe, Masashi Fujita, Nobukazu Tanabe, Yoshiya Yamamoto, Masaru Baba, Takashi Meguro, Naoya Sakamoto, Yoshiyuki Ueno, Takayuki Matsumoto

    Published: 2026-11-17DOI: 10.1159/lic/admag030

  2. Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study

    Ko Hashimoto, Tomokazu Kawaoka, Tomoaki Emori, Aiko Tanaka, Yuki Shirane, Ryoichi Miura, Yasutoshi Fujii, Hikaru Nakahara, Kenji Yamaoka, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Daiki Miki, C. Nelson Hayes, Akira Hiramatsu, Kei Amioka, Michihiro Nonaka, Yasuyuki Aisaka, Kei Morio, Takashi Moriya, Yuji Teraoka, Hirotaka Kono, Yosuke Suehiro, Keiichi Masaki, Kazuki Ohya, Shintaro Takaki, Nami Mori, Keiji Tsuji, Yumi Kosaka, Takashi Nakahara, Hiroshi Aikata, Masataka Tsuge, Shiro Oka

    Published: 2025-12-09DOI: 10.1159/000549979

  3. Change in Liver Function after Selective Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: JIVROSG-2001 PRESIDENT-ALBI – A Secondary Analysis of a Multicenter Randomized Controlled Trial

    Yoshihisa Kodama, Masafumi Ikeda, Yasuaki Arai, Yoshitaka Inaba, Toshihiro Tanaka, Yasunori Arai, Shunsuke Sugawara, Hajime Yamazaki, Takeshi Aramaki, Hiroshi Anai, Shinichi Morita, Yasunari Fujinaga, Hiroshi Seki, Mikio Sato, Kenya Kamimura, Junji Ito, Masakatsu Tsurusaki, Tetsuro Nakazawa, Hiroyuki Tokue, Daisuke Abo, Kenichi Kato, Natsuko Hayashi, Osamu Sato, Miyuki Sone

    Published: 2025-12-05DOI: 10.1159/000549879

  4. Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic Therapy

    Camilla De Carlo, Reha Akpinar, Barbara Durante, Tiziana Pressiani, Julien Calderaro, Salvatore Lorenzo Renne, Angelo Pirozzi, Elena Valenzi, Irene Oi-lin Ng, Tan To Cheung, Albino Eccher, Pamela Sighinolfi, Erica Villa, Massimo Iavarone, Marco Maggioni, Yu-Yun Shao, Sara Lonardi, Mario Domenico Rizzato, Antonio De Rosa, Matteo Fassan, Valentina Angerilli, Federica Pedica, Margherita Rimini, Andrea Casadei Gardini, Armando Santoro, Young Nyun Park, Massimo Roncalli, Luigi Terracciano, Salvatore Piscuoglio, Lorenza Rimassa, Luca Di Tommaso

    Published: 2025-09-19DOI: 10.1159/000547669

  5. China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition)

    Jian Zhou, Huichuan Sun, Zheng Wang, Wenming Cong, Mengsu Zeng, Weiping Zhou, Lianxin Liu, Tianfu Wen, Ming Kuang, Bixiang Zhang, Kaishan Tao, Guohong Han, Zhiping Yan, Maoqiang Wang, Ruibao Liu, Jinhe Guo, Zhaochong Zeng, Ping Liang, Zhenggang Ren, Jinlin Hou, Yanqiao Zhang, Xiufeng Liu, Hongming Pan, Feng Bi, Changhong Liang, Min Chen, Fuhua Yan, Huixiong Xu, Xiaoyan Xie, Shenghong Ju, Yuan Ji, Jingping Yun, Zengshan Li, Xueli Bai, Dingfang Cai, Weixia Chen, Yajin Chen, Yongjun Chen, Wenwu Cheng, Shuqun Cheng

    Published: 2025-07-10DOI: 10.1159/000546574

  6. Primary Analysis of a Phase II Study of Atezolizumab plus Bevacizumab for TACE-Unsuitable Patients with Tumor Burden beyond Up-To-Seven Criteria in Intermediate-Stage Hepatocellular Carcinoma: REPLACEMENT Study

    Masatoshi Kudo, Kazuomi Ueshima, Kaoru Tsuchiya, Tatsuya Yamashita, Shigeo Shimose, Kazushi Numata, Yuzo Kodama, Shinji Itoh, Yasuhito Tanaka, Hidekatsu Kuroda, Hiroshi Aikata, Atsushi Hiraoka, Michihisa Moriguchi, Ryosuke Tateishi, Sadahisa Ogasawara, Kouji Yamamoto, Masafumi Ikeda

    Published: 2025-06-19DOI: 10.1159/000546899

  7. Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational Study

    Yoon Jun Kim, Philippe Merle, Richard S. Finn, Masatoshi Kudo, Heinz-Josef Klümpen, Ho Yeong Lim, Masafumi Ikeda, Alessandro Granito, Gianluca Masi, René Gerolami, Sung Bum Cho, Chih-Hung Hsu, Yi-Hsiang Huang, Long-Bin Jeng, Do Young Kim, Shi-Ming Lin, Matthias Pinter, Guoliang Shao, Naoya Kato, Masayuki Kurosaki, Kazushi Numata, Kung-Kai Kuo, Yilei Mao, Yih-Jyh Lin, Kangshun Zhu, Philip Twumasi-Ankrah, Javeed Khan, Maria Awan, Kirhan Ozgurdal, Shukui Qin

    Published: 2024-12-18DOI: 10.1159/000542285

  8. Probability of Lymph Node Metastases in Patients Undergoing Adequate Lymphadenectomy during Surgery for Intrahepatic Cholangiocarcinoma: A Retrospective Multicenter Study

    Carlo Sposito, Alessandro Cucchetti, Francesca Ratti, Laura Alaimo, Francesco Ardito, Stefano Di Sandro, Matteo Serenari, Giammauro Berardi, Marianna Maspero, Giuseppe Maria Ettorre, Matteo Cescon, Fabrizio Di Benedetto, Felice Giuliante, Andrea Ruzzenente, Giorgio Ercolani, Luca Aldrighetti, Vincenzo Mazzaferro

    Published: 2024-10-16DOI: 10.1159/000541646

Volumes

2026 · 572025 · 842024 · 892023 · 652022 · 682021 · 682020 · 822019 · 642018 · 472017 · 552016 · 332015 · 312014 · 242013 · 252012 · 26

Znalosti, které odpovídají vaší práci.

Od bezplatného začátku přes osobní rešerše literatury až po kompletní Research Suite.

Zobrazit tarify →

Jsou zahrnuty všechny plné texty vydavatelů?

Ne. Bibliografické záznamy, abstrakty a plné texty jsou různé typy obsahu. To, zda je plný text dostupný, závisí na zdroji, Open Access a vašich stávajících licencích. Tarif EUVIMED nenahrazuje dodatečná vydavatelská práva.